Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in Primary Sjögren's Syndrome
NCT05087589Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Nov 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib oral solution in primary Sjögren's syndrome, sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
tofacitinib oral solution
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT05087589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087589.